Atlas Trials

A Phase 4 Study to Evaluate Response to Treatment and Safety of Paliperidone Extended-Release in Participants With Schizophrenia

Clinical trial NCT00915512 · COMPLETED

Trial details

NCT number
NCT00915512
Sponsor
Janssen-Cilag Turkey
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2009-05-01
Primary completion
2011-10-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.